{"id":246722,"date":"2026-09-15T12:59:02","date_gmt":"2026-09-15T07:29:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=246722"},"modified":"2026-09-15T12:59:02","modified_gmt":"2026-09-15T07:29:02","slug":"why-bliss-gvs-pharma-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/","title":{"rendered":"Bliss GVS Pharma (BLISSGVS-BE) Share Price Falls 5% Today to Rs 686.35"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em>Bliss GVS Pharma (BLISSGVS-BE)share price fell to Rs 686.35 today, down 5% from the previous close. Market cap was Rs 7,681.84 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Bliss GVS Pharma Share Price fell to Rs 686.35 on 15 September 2026, down 5% from the previous close of Rs 722.45, taking the company\u2019s market capitalisation to Rs 7,681.84 crore. The Mid Cap pharmaceutical stock is drawing attention because the day\u2019s decline was sharp enough to stand out, even though the broader supplied data does not establish any company-specific catalyst for the move.<\/p>\n<p>For investors tracking Bliss GVS Pharma Share Price Today, the session matters for three reasons. First, the stock opened lower at Rs 698.10 and moved down to its intraday low of Rs 686.35 after touching a day high of Rs 722. Second, the turnover stood at Rs 0.61 crore, confirming active price discovery around the decline. Third, the stock still sits above its 50-day moving average of Rs 583.93 and 200-day moving average of Rs 379.64, while its core valuation and profitability ratios place it in an interesting position within the Healthcare and Pharmaceuticals &#038; Drugs space. On Univest, that combination makes this one of the more notable stock updates in today\u2019s market news.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Bliss_GVS_Pharma_BLISSGVS-BE_Share_Price_Today_Price_Action_Analysis\" title=\"Bliss GVS Pharma (BLISSGVS-BE) Share Price Today: Price Action Analysis\">Bliss GVS Pharma (BLISSGVS-BE) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Bliss_GVS_Pharma_BLISSGVS-BE_Fundamental_Analysis\" title=\"Bliss GVS Pharma (BLISSGVS-BE) Fundamental Analysis\">Bliss GVS Pharma (BLISSGVS-BE) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Bliss_GVS_Pharma\" title=\"Why Investors Are Watching Bliss GVS Pharma\">Why Investors Are Watching Bliss GVS Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#About_Bliss_GVS_Pharma\" title=\"About Bliss GVS Pharma\">About Bliss GVS Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Track_Bliss_GVS_Pharma_Share_Price_on_Univest\" title=\"Track Bliss GVS Pharma Share Price on Univest\">Track Bliss GVS Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Why_did_Bliss_GVS_Pharma_Share_Price_fall_today\" title=\"Why did Bliss GVS Pharma Share Price fall today?\">Why did Bliss GVS Pharma Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#What_is_Bliss_GVS_Pharma_Share_Price_Today\" title=\"What is Bliss GVS Pharma Share Price Today?\">What is Bliss GVS Pharma Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#What_does_todays_price_action_show_for_Bliss_GVS_Pharma\" title=\"What does today\u2019s price action show for Bliss GVS Pharma?\">What does today\u2019s price action show for Bliss GVS Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#Is_Bliss_GVS_Pharma_a_Mid_Cap_stock\" title=\"Is Bliss GVS Pharma a Mid Cap stock?\">Is Bliss GVS Pharma a Mid Cap stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#How_is_Bliss_GVS_Pharma_valued_compared_with_its_industry\" title=\"How is Bliss GVS Pharma valued compared with its industry?\">How is Bliss GVS Pharma valued compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#What_do_Bliss_GVS_Pharma_profitability_ratios_indicate\" title=\"What do Bliss GVS Pharma profitability ratios indicate?\">What do Bliss GVS Pharma profitability ratios indicate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#What_are_the_key_per-share_metrics_for_Bliss_GVS_Pharma\" title=\"What are the key per-share metrics for Bliss GVS Pharma?\">What are the key per-share metrics for Bliss GVS Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#How_does_Bliss_GVS_Pharma_compare_with_major_pharma_peers\" title=\"How does Bliss GVS Pharma compare with major pharma peers?\">How does Bliss GVS Pharma compare with major pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-fall-today-2026\/#What_should_investors_monitor_next_in_Bliss_GVS_Pharma_Stock_News\" title=\"What should investors monitor next in Bliss GVS Pharma Stock News?\">What should investors monitor next in Bliss GVS Pharma Stock News?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_BLISSGVS-BE_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Bliss GVS Pharma (BLISSGVS-BE) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 686.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 722.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 36.10 (-5%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 698.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 722<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 686.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.61 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,681.84 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Bliss GVS Pharma Share Price Today reflects a clear same-day decline, with the stock falling Rs 36.10 from Rs 722.45 to Rs 686.35, a move of -5%. The session began at Rs 698.10, which already placed the stock below the previous close, and the day high of Rs 722 shows it briefly tested levels near the prior settlement before weakening. The day low of Rs 686.35 also matches the current traded price in the supplied data, indicating the stock was at the lower end of its intraday range at the time of this update.<\/p>\n<p>Turnover of Rs 0.61 crore suggests the price move drew market participation even as the stock eased. For a Mid Cap name with a market cap of Rs 7,681.84 crore, that makes the day\u2019s price action relevant for traders watching near-term levels and investors tracking Bliss GVS Pharma Share News. Importantly, the supplied data confirms the share price decline but does not establish a company-specific reason for why Bliss GVS Pharma Stock Falling Today. That shifts attention from headline speculation to how the stock is positioned on valuation, profitability and broader industry comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_BLISSGVS-BE_Fundamental_Analysis\"><\/span><strong>Bliss GVS Pharma (BLISSGVS-BE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,681.84 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">56.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.11%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 12.81<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 115.94<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.21%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Bliss GVS Pharma Fundamental Analysis shows a company valued at Rs 7,681.84 crore with a price-to-earnings ratio of 56.41 and a price-to-book ratio of 6.23. EPS stands at Rs 12.81, which represents earnings attributable to each share, while book value per share is Rs 115.94, indicating the accounting net worth behind each share. The dividend yield is 0.21, which points to a relatively modest historical payout relative to the current stock price.<\/p>\n<p>From a profitability angle, return on equity is 12.11% and return on capital employed is 17.4%. Those figures indicate the business is generating returns above double digits, with ROCE stronger than ROE. The valuation multiples, however, show that the market is assigning a richer earnings and book-value multiple to the stock than many companies typically trade at in this industry. That does not automatically make the stock overvalued or undervalued, but it does mean the Bliss GVS Pharma Share Price is being judged against a relatively demanding set of expectations. For readers following Bliss GVS Pharma Financial Results and Bliss GVS Pharma Earnings, the balance between valuation and operating returns is central to the present stock analysis on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">56.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.15x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.34x to 693.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.37x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.11%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.54%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,681.84 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 704.59 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,873.11 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The sector benchmark places the stock in Healthcare, specifically the Pharmaceuticals &#038; Drugs industry, and that context is important because it shows where Bliss GVS Pharma sits relative to 204 same-industry companies. In this benchmark set, the company\u2019s P\/E of 56.41 is above the industry median of 32.72 and also above the average of 49.15. The broader P\/E range is wide, from 3.34 to 693.7 across 169 companies, so the stock is not an outlier at the extreme end, but it is clearly trading above the middle of the industry pack.<\/p>\n<p>The same pattern appears in price-to-book. Bliss GVS Pharma trades at 6.23 times book value, above the industry median of 3.05 and the average of 4.37, across 203 companies. On profitability, the picture is steadier. Its ROE of 12.11% is slightly above the industry median of 11.69% and above the average of 10.54. ROCE of 17.4% is also ahead of the median of 13.24% and average of 13.09. In market-cap terms, Bliss GVS Pharma at Rs 7,681.84 crore is well above the industry median of Rs 704.59 crore, though below the average of Rs 13,873.11 crore in a sector where the range runs from Rs 3.8 crore to Rs 4,41,957.5 crore. For investors reading Bliss GVS Pharma Stock News, the takeaway is a stock with above-benchmark valuation and better-than-benchmark operating return ratios.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,41,957.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,47,576<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,233.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,670.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,272.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Peer comparison shows Bliss GVS Pharma operating in a far smaller size bracket than major listed pharmaceutical companies, but its valuation and return profile still invite direct comparison. Against Sun Pharmaceutical Industries, Cipla and Zydus Lifesciences, Bliss GVS Pharma carries a higher P\/E than Sun Pharma\u2019s 36.54, Cipla\u2019s 32.72 and Zydus Lifesciences\u2019 24.74. It is lower than Divi\u2019s Laboratories at 84.64 and Torrent Pharmaceuticals at 86.76. That places the stock in the upper valuation half of this peer set.<\/p>\n<p>On profitability, Bliss GVS Pharma\u2019s ROE of 12.11% is above Cipla\u2019s 11.83 and Aurobindo Pharma\u2019s 9.93 in the wider benchmark list, but below Sun Pharma\u2019s 14.85, Divi\u2019s 16.19, Zydus Lifesciences\u2019 19.69 and Torrent Pharmaceuticals\u2019 26.76. Its ROCE of 17.4% is stronger than Cipla\u2019s 16.00, but trails Sun Pharma\u2019s 19.11, Divi\u2019s 21.51, Zydus Lifesciences\u2019 21.39 and Torrent\u2019s 19.27. The market-cap gap is even more pronounced, with Bliss GVS Pharma at Rs 7,681.84 crore versus peers running from Rs 1,10,272.68 crore for Cipla to Rs 4,41,957.5 crore for Sun Pharma. On Univest, that makes Bliss GVS Pharma Share Price a case of a smaller pharma company trading on relatively full multiples compared with several much larger peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Bliss_GVS_Pharma\"><\/span><strong>Why Investors Are Watching Bliss GVS Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Sharp daily move:<\/strong>&nbsp;the stock declined 5% to Rs 686.35, down Rs 36.10 from Rs 722.45.<\/li>\n<li><strong>Intraday weakness:<\/strong>&nbsp;it opened at Rs 698.10, touched Rs 722 and slipped to a low of Rs 686.35.<\/li>\n<li><strong>Rich valuation:<\/strong>&nbsp;the P\/E of 56.41 and P\/B of 6.23 are above industry median levels.<\/li>\n<li><strong>Profitability support:<\/strong>&nbsp;ROE of 12.11% and ROCE of 17.4% are above sector median benchmarks.<\/li>\n<li><strong>Trend context:<\/strong>&nbsp;the stock remains above its 50 DMA of Rs 583.93 and 200 DMA of Rs 379.64.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Bliss_GVS_Pharma\"><\/span><strong>About Bliss GVS Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bliss GVS Pharma operates in the Healthcare sector and is part of the Pharmaceuticals &#038; Drugs industry. Based on the supplied classification, the company sits in the listed pharma universe where investors often compare stocks on earnings multiples, return ratios and market capitalisation. With a market cap of Rs 7,681.84 crore, it is meaningfully larger than the industry median company size of Rs 704.59 crore, though much smaller than the biggest established pharmaceutical players in the benchmark group. That positioning helps explain why Bliss GVS Pharma Latest News and Bliss GVS Pharma Company News attract interest when the share price shows notable intraday movement.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Bliss_GVS_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Bliss GVS Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>On Univest, users can track Bliss GVS Pharma Share Price Live alongside key market data points such as daily price action, market capitalisation, valuation ratios, moving averages, 52-week levels and sector comparisons. Univest also helps investors follow Bliss GVS Pharma Stock Analysis through profitability metrics like ROE, ROCE, EPS, book value and dividend yield, making it easier to place a single-day move in broader context without jumping to unsupported conclusions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Bliss_GVS_Pharma_Share_Price_fall_today\"><\/span><strong>Why did Bliss GVS Pharma Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Bliss GVS Pharma Share Price fell 5% to Rs 686.35 from the previous close of Rs 722.45. The supplied data confirms the decline and intraday weakness, but it does not establish any company-specific catalyst behind today\u2019s move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Bliss_GVS_Pharma_Share_Price_Today\"><\/span><strong>What is Bliss GVS Pharma Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Bliss GVS Pharma Share Price Today is Rs 686.35 as of the supplied update. The stock was down Rs 36.10 or 5%, after opening at Rs 698.10 and moving within an intraday range of Rs 686.35 to Rs 722.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Bliss_GVS_Pharma\"><\/span><strong>What does today\u2019s price action show for Bliss GVS Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Today\u2019s price action shows a weak session. The stock opened below the previous close, briefly reached Rs 722, and then slipped to Rs 686.35, which was also the day\u2019s low at the time of the update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Bliss_GVS_Pharma_a_Mid_Cap_stock\"><\/span><strong>Is Bliss GVS Pharma a Mid Cap stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Yes, Bliss GVS Pharma is classified as a Mid Cap stock in the supplied data. Its market capitalisation stands at Rs 7,681.84 crore, placing it above the industry median company size of Rs 704.59 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Bliss_GVS_Pharma_valued_compared_with_its_industry\"><\/span><strong>How is Bliss GVS Pharma valued compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Bliss GVS Pharma trades at a P\/E of 56.41, above the same-industry median of 32.72 and average of 49.15. Its P\/B of 6.23 is also above the industry median of 3.05 and average of 4.37.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Bliss_GVS_Pharma_profitability_ratios_indicate\"><\/span><strong>What do Bliss GVS Pharma profitability ratios indicate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The company\u2019s ROE is 12.11% and ROCE is 17.4%. Both are above the Pharmaceuticals &amp; Drugs industry median levels of 11.69% and 13.24%, indicating profitability metrics that are stronger than the benchmark midpoint.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_per-share_metrics_for_Bliss_GVS_Pharma\"><\/span><strong>What are the key per-share metrics for Bliss GVS Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Bliss GVS Pharma reports EPS of Rs 12.81, book value of Rs 115.94 per share and dividend yield of 0.21. These figures help investors assess earnings support, net worth backing and the stock\u2019s historical payout profile.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bliss_GVS_Pharma_compare_with_major_pharma_peers\"><\/span><strong>How does Bliss GVS Pharma compare with major pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Bliss GVS Pharma is much smaller by market cap than peers such as Sun Pharma, Cipla, Zydus Lifesciences, Divi\u2019s and Torrent Pharmaceuticals. Its P\/E is higher than Sun, Cipla and Zydus, but lower than Divi\u2019s and Torrent.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Bliss_GVS_Pharma_Stock_News\"><\/span><strong>What should investors monitor next in Bliss GVS Pharma Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors should monitor whether Bliss GVS Pharma Share Price stabilises after falling to Rs 686.35, and whether valuation at 56.41 times earnings continues to align with ROE of 12.11% and ROCE of 17.4%.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bliss GVS Pharma Share Price falls to Rs 686.35. marking a 5% fall today. Market cap stands at Rs 7,681.84 crore.<\/p>\n","protected":false},"author":29,"featured_media":246718,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-246722","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["246718"],"rank_math_title":["Bliss GVS Pharma Share Price Today: 5% Decline Analysis"],"rank_math_description":["Bliss GVS Pharma Share Price is under pressure today after a 5% fall. Review valuation, profitability ratios and industry benchmark numbers."],"rank_math_focus_keyword":["Bliss GVS Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Bliss_GVS_Pharma_BLISSGVS_BE_Share_Price_Falls_5_Today_to_Rs_68635_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=246722"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246722\/revisions"}],"predecessor-version":[{"id":246723,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246722\/revisions\/246723"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/246718"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=246722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=246722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=246722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}